All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 96 of 206 pages ‹ First < 94 95 96 97 98 > Last ›
HSL7669
McCarthy M.
US institute seeks to bridge bench-to-bedside gap.
Lancet Neurol 2007 Jan;6:(1):22-3
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17195349&dopt=Abstract
HSL7675
Woosley RL, Cossman J.
Drug development and the FDA's Critical Path Initiative.
Clin Pharmacol Ther 2007 Jan;81:(1):129-33
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17186012&dopt=Abstract
HSL7695
Ridberg R, Producer & Editor
Big Bucks, Big Pharma; Marketing Disease & Pushing Drugs
: Media Education Foundation 2007 Jan
http://www.mediaed.org/videos/MediaAndHealth/BigBucksBigPharma/#articles
HSL8016
Geppert CM.
Medical education and the pharmaceutical industry: a review of ethical guidelines and their implications for psychiatric training.
Acad Psychiatry 2007 Jan-Feb;31:(1):32-9
http://ap.psychiatryonline.org/cgi/content/full/31/1/32
HSL8024
Bradley JS, Guidos R, Baragona S, Bartlett JG, Rubinstein E, Zhanel GG, Tino MD, Pompliano DL, Tally F, Tipirneni P, Tillotson GS, Powers JH, Tillotson GS.
Anti-infective research and development--problems, challenges, and solutions.
Lancet Infect Dis 2007 Jan;7:(1):68-78
http://linkinghub.elsevier.com/retrieve/pii/S1473-3099(06)70689-2
HSL8044
Abusief ME, Hornstein MD, Jain T; American Society for Reproductive Medicine; Society for Assisted Reproductive Technology.
Assessment of United States fertility clinic websites according to the American Society for Reproductive Medicine (ASRM)/Society for Assisted Reproductive Technology (SART) guidelines.
Fertil Steril 2007 Jan;87:(1):88-92
http://linkinghub.elsevier.com/retrieve/pii/S0015-0282(06)03167-0
HSL8514
Hyman PL, Hochman ME, Shaw JG, Steinman MA.
Attitudes of preclinical and clinical medical students toward interactions with the pharmaceutical industry.
Acad Med 2007 Jan;82:(1):94-9
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00001888-200701000-00014
HSL8663
Eibling DE.
How to end med confusion.
Hosp Health Netw 2007 Jan;81:(1):8,
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17315300&dopt=Abstract
HSL8675
Chaves GC, Oliveira MA.
A proposal for measuring the degree of public health-sensitivity of patent legislation in the context of the WTO TRIPS Agreement.
Bull World Health Organ 2007 Jan;85:(1):49-56
http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862007000100012&lng=en&nrm=iso&tlng=en
HSL8680
Petrocelli JV, Tormala ZL, Rucker DD.
Unpacking attitude certainty: attitude clarity and attitude correctness.
J Pers Soc Psychol 2007 Jan;92:(1):30-41
http://content.apa.org/journals/psp/92/1/30
HSL8681
Newcombe JP, Kerridge IH.
Assessment by human research ethics committees of potential conflicts of interest arising from pharmaceutical sponsorship of clinical research.
Intern Med J 2007 Jan;37:(1):12-7
http://www.blackwell-synergy.com/doi/full/10.1111/j.1445-5994.2006.01234.x
HSL8715
Keim B.
Europe's sweeping chemical law puts medicines in peril.
Nat Med 2007 Jan;13:(1):4
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17297677&query_hl=8&itool=pubmed_DocSum
HSL8747
Mendell JR, Csimma C, McDonald CM, Escolar DM, Janis S, Porter JD, Hesterlee SE, Howell RR.
Challenges in drug development for muscle disease: a stakeholders' meeting.
Muscle Nerve 2007 Jan;35:(1):8-16
http://www3.interscience.wiley.com/cgi-bin/abstract/113441314/ABSTRACT?CRETRY=1&SRETRY=0
HSL8783
Lieberman T.
The Epidemic
Columbia Journalism Review 2007 Jan-Feb
http://www.cjr.org/issues/2007/2/Lieberman.asp
HSL8795
Caughey AB, Urato AC.
Financial relationships between research and pharmaceutical/biotech companies: disclosure is imperative.
Am J Obstet Gynecol 2007 Jan;196:(1):e13
http://linkinghub.elsevier.com/retrieve/pii/S0002-9378(06)00943-4
HSL8961
Nicholas A, Divine H, Nowak-Rapp M, Roberts KB.
University and college of pharmacy collaboration to control health plan prescription drug costs.
J Am Pharm Assoc (Wash DC) 2007 Jan-Feb;47:(1):86-92
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17338480&query_hl=5&itool=pubmed_DocSum
HSL8999
Obama B.
The genomics and Personalized Medicine Act of 2006.
Clin Adv Hematol Oncol 2007 Jan;5:(1):39-40
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17339825&query_hl=1&itool=pubmed_DocSum
HSL9014
Taylor JA.
Saving the sample closet.
Fam Pract Manag 2007 Jan;14:(1):11
http://www.aafp.org/fpm/20070100/letters.html
HSL9023
Haddow G, Laurie G, Cunningham-Burley S, Hunter KG.
Tackling community concerns about commercialisation and genetic research: a modest interdisciplinary proposal.
Soc Sci Med 2007 Jan;64:(2):272-82
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VBF-4M3RPBX-1&_user=10&_coverDate=01%2F31%2F2007&_rdoc=1&_fmt=full&_orig=search&_cdi=5925&_sort=d&_docanchor=&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=cf0498c9e82e559ccdc92f4bdb7284e3
HSL9041
Minhas R.
Statin utilisation--recognising the role of the invisible hand.
Int J Clin Pract 2007 Jan;61:(1):3-6
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17229171&query_hl=1&itool=pubmed_DocSum
HSL9250
Somberg J.
The hypertension peril and drug development.
Am J Ther 2007 Jan-Feb;14:(1):2
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00045391-200701000-00002
HSL9258
Gunderman RB, Dodd GC.
Persuasion in radiology.
Acad Radiol 2007 Jan;14:(1):100-4
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17236275&query_hl=13&itool=pubmed_DocSum
HSL9817
Guyer RL.
How to influence state legislatures and regulatory agencies.
Physician Exec 2007 Jan-Feb;33:(1):18-22
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17354995&query_hl=17&itool=pubmed_DocSum
HSL9822
Slavin S, Batrouney C, Murphy D.
Fear appeals and treatment side-effects: an effective combination for HIV prevention?
AIDS Care 2007 Jan;19:(1):130-7
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17129868&query_hl=22&itool=pubmed_DocSum
HSL9823
Hilton P.
Of porcupines and poodles--a joint challenge to industry and the profession.
Int Urogynecol J Pelvic Floor Dysfunct 2007 Jan;18:(1):3-11
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17024519&query_hl=23&itool=pubmed_DocSum
HSL9838
Cohen JS.
More Doctors And Medical Centers Are Going 'Pharm-free'.
MedicationSense.com 2007 Jan-Apr
http://www.medicationsense.com/articles/jan_apr_07/pharm_free_041507.html
HSL9983
Lexchin J.
Of Money and Trust in Biomedical Care
Mens Sana Monographs 2007 Jan-Dec;5:(1):7-10
http://www.msmonographs.org/article.asp?issn=0973-1229;year=2007;volume=5;issue=1;spage=7;epage=10;aulast=Lexchin
HSL10131
Novak E, Allen PJ.
Prescribing medications in pediatrics: concerns regarding FDA approval and pharmacokinetics.
Pediatr Nurs 2007 Jan-Feb;33:(1):64-70
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17411005&query_hl=4&itool=pubmed_DocSum
HSL10135
Allen LaPointe NM, Pappas P, Deverka P, Anstrom KJ.
Patient receipt and understanding of written information provided with isotretinoin and estrogen prescriptions.
J Gen Intern Med 2007 Jan;22:(1):98-101
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=17351847
HSL10198
Baumevieille M, Begaud B, Maurain C.
[Charter of medicines promotion and rational use by physicians].
Therapie 2007 Jan-Feb;62:(1):39-44
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17374346&query_hl=16&itool=pubmed_DocSum
HSL10558
Balakrishnan K, Tordoff J, Norris P, Reith D.
Establishing a baseline for the monitoring of medicines availability for children in the UK: 1998-2002.
Br J Clin Pharmacol 2007 Jan;63:(1):85-91
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2125.2006.02729.x
HSL10699
Spooner JJ, Gandhi PK, Connelly SB.
AMCP Format dossier requests: manufacturer response and formulary implications for one large health plan.
J Manag Care Pharm 2007 Jan-Feb;13:(1):37-43
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17269835&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL10701
Califf RM; CERTs Benefit Assessment Workshop Participants.
Benefit assessment of therapeutic products: the Centers for Education and Research on Therapeutics.
Pharmacoepidemiol Drug Saf 2007 Jan;16:(1):5-16
http://www3.interscience.wiley.com/cgi-bin/abstract/112466944/ABSTRACT?CRETRY=1&SRETRY=0
HSL10762
Terleira A, Portoles A, Rojas A, Vargas E.
Effect of drug-test interactions on length of hospital stay.
Pharmacoepidemiol Drug Saf 2007 Jan;16:(1):39-45
http://www3.interscience.wiley.com/cgi-bin/abstract/113385322/ABSTRACT?CRETRY=1&SRETRY=0
HSL11189
Borchers AT, Hagie F, Keen CL, Gershwin ME.
The history and contemporary challenges of the US Food and Drug Administration.
Clin Ther 2007 Jan;29:(1):1-16
http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6VRS-4NB49P0-2-1&_cdi=6242&_user=10&_orig=search&_coverDate=01%2F31%2F2007&_sk=999709998&view=c&wchp=dGLbVzW-zSkWb&md5=981dd4220d6a9bd0442eee771de5ed38&ie=/sdarticle.pdf
HSL11436
Miller J.
The other side of trust in health care: prescribing drugs with the potential for abuse.
Bioethics 2007 Jan;21:(1):51-60
http://www.blackwell-synergy.com/doi/full/10.1111/j.1467-8519.2007.00523.x
HSL11439
Coyne DW.
Influence of industry on renal guideline development.
Clin J Am Soc Nephrol 2007 Jan;2:(1):3-7
http://cjasn.asnjournals.org/cgi/content/full/2/1/3
HSL11554
Vergel N.
The end of nandrolone.
GMHC Treat Issues 2007 Jan-Mar;21:(1):1-3
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17722330
HSL11667
[No authors listed].
Abbott Laboratories backlists Thailand from new AIDS/HIV drugs.
Monash Bioeth Rev. 2007 Jan- Apr;26:(1-2):11
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17867317
HSL12357
Davis JJ, Cross E, Crowley J.
Pharmaceutical websites and the communication of risk information.
J Health Commun 2007 Jan-Feb;12:(1):29-39
http://www.informaworld.com/smpp/content?content=10.1080/10810730601091326
HSL19034
Wilson CT, Woloshin S, Schwartz LM.
Choosing where to have major surgery: who makes the decision?
Arch Surg 2007;142:(3):242-6
http://archsurg.ama-assn.org/cgi/content/full/142/3/242
HSL19032
Herndon MB, Schwartz LM, Woloshin S, Welch HG.
Implications of expanding disease definitions: the case of osteoporosis.
Health Aff (Millwood) 2007;26:(6):1702-11
http://content.healthaffairs.org/content/26/6/1702.long
HSL19031
Welch HG, Woloshin S, Schwartz LM, Gordis L, Gøtzsche PC, Harris R, Kramer BS, Ransohoff DF.
Overstating the evidence for lung cancer screening: the International Early Lung Cancer Action Program (I-ELCAP) study.
Arch Intern Med 2007 26;167:(21):2289-95
http://archinte.ama-assn.org/cgi/content/full/167/21/2289
HSL7214
Cohen D.
Should the use of selective serotonin reuptake inhibitors in child and adolescent depression be banned?
Psychother Psychosom 2007;76:(1):5-14
http://content.karger.com/produktedb/produkte.asp?typ=fulltext&file=000096360
HSL7389
Hurley D.
Modern Snake Oil? NATURAL CAUSES: Death, Lies, and Politics in America's Vitamin and Herbal Supplement Industry
: Broadway 2007
http://www.businessweek.com/magazine/content/07_02/b4016109.htm
HSL7451
US FDA
FDA's Electronic Freedom of Information Reading Room - Warning Letters and Responses
Rockville, MD: US FDA 2007
http://www.fda.gov/foi/warning.htm
HSL7587
Dowden JS.
Product information past perfect
Med J Aust 2007;186:(2):51-52
http://www.mja.com.au/public/issues/186_02_150107/dow11056_fm.html
HSL7588
Stockigt JR.
Barriers in the quest for quality drug information: salutary lessons from TGA-approved sources for thyroid-related medications
Med J Aust 2007;186:(2):76-79
http://www.mja.com.au/public/issues/186_02_150107/sto10229_fm.html
HSL8017
Du W, Levine M, Wang L, Zhang Y, Yi C, Wang H, Wang X, Xie H, Xu J, Jin H, Wang T, Huang G, Wu Y.
Building a structured monitoring and evaluating system of postmarketing drug use in Shanghai.
Can J Clin Pharmacol 2007 Win;14:(1):e40-4
http://www.cjcp.ca/pdf/CJCP2007_e40_e44.pdf
HSL8065
Frosch DL, Krueger PM, Hornik RC, Cronholm PF, Barg FK.
Creating Demand for Prescription Drugs: A Content Analysis of Television Direct-to-Consumer Advertising
Annals of Family Medicine 2007;5:6-13
http://www.annfammed.org/cgi/content/full/5/1/6
HSL8206
Kessler DA.
Direct-to-Consumer Advertising: Is It Too Late to Manage the Risks?
Annals of Family Medicine 2007;5:(1):4-5
http://www.annfammed.org/cgi/content/full/5/1/4
HSL8208
Stange KC.
In This Issue: Doctor-Patient and Drug Company-Patient Communication
Annals of Family Medicine 5:2-4 (2007) 2007;5:(1):2-4
http://www.annfammed.org/cgi/content/full/5/1/2
HSL8209
Goodman RL.
Medical education and the pharmaceutical industry.
Perspect Biol Med 2007 Win;50:(1):32-9
http://www.ncbi.nlm.nih.gov/pubmed/17259674
HSL8210
Moffatt B, Elliott C.
Ghost marketing: pharmaceutical companies and ghostwritten journal articles.
Perspect Biol Med 2007 Win;50:(1):18-31
http://muse.jhu.edu/cgi-bin/access.cgi?uri=/journals/perspectives_in_biology_and_medicine/v050/50.1moffatt.html
HSL8247
Fleg AN.
Introduction to pharmaceuticology
studentBMJ 2007;15:45-88
http://www.studentbmj.com/issues/07/02/life/78.php
HSL8248
Bernal L.
Why Pharma Must Go Hollywood
The Scientist 2007;21:(2):42
http://www.the-scientist.com/2007/2/1/42/1/
HSL8678
Koren G, MacLeod S, Davis D.
Drugs in pregnancy: acknowledging challenges--finding solutions.
Can J Clin Pharmacol 2007 Win;14:(1):e2-4
http://www.cjcp.ca/pdf/CJCP2007_e2_e4.pdf
HSL8679
Finkelstein Y, Rezvani M, Garcia-Bournissen F, Nurmohamed L, Koren G.
Inactive pharmaceutical ingredients : implications for pregnancy.
Can J Clin Pharmacol 2007 Win;14:(1):e17-28
http://www.cjcp.ca/pdf/CJCP2007_e17_e28.pdf
HSL8749
Maggioni AP, Darne B, Atar D, Abadie E, Pitt B, Zannad F; 5th Cardiovascular Clinical Trialists Workshop.
FDA and CPMP rulings on subgroup analyses.
Cardiology 2007;107:(2):97-102
http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowFulltext&ArtikelNr=94508&Ausgabe=232050&ProduktNr=223832
HSL8768
Lewis WR.
Pros and cons of the pharmaceutical industry and education.
Prev Cardiol 2007 Winter;10:(1):5-6
http://www.lejacq.com/Search_articleDetail.cfm?aid=PC5977%2DLewis%2Epdf&CFID=1869878&CFTOKEN=77879140
HSL8822
Brody H.
Hooked: Ethics, the Medical Profession and the Pharmaceutical Industry.
Lanham, MD: Rowman & Littlefield 2007
http://web.archive.org/web/20070429232434/http://www.rowmanlittlefield.com/Catalog/SingleBook.shtml?command=Search&db=%5EDB/CATALOG.db&eqSKUdata=0742552195&thepassedurl=[thepassedurl]
HSL8911
BUKO Pharma-Kampagne
Counterfeit medicines – what are the problems?
Bielefeld, Germany: BUKO Pharma-Kampagne 2007
http://www.bukopharma.de/Service/Archiv/E2007_01_special.pdf
HSL8962
Stossel TP.
Regulation of financial conflicts of interest in medical practice and medical research: a damaging solution in search of a problem.
Perspect Biol Med 2007 Win;50:(1):54-71
http://muse.jhu.edu/login?uri=/journals/perspectives_in_biology_and_medicine/v050/50.1stossel.html
HSL9015
Day RO, Williams KM.
Open-label extension studies: do they provide meaningful information on the safety of new drugs?
Drug Saf 2007;30:(2):93-105
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17253876&query_hl=6&itool=pubmed_DocSum
HSL9363
Clark RC, Maxwell SR, Kerr S, Cuthbert M, Buchanan D, Steinke D, Webb DJ, Bateman ND.
The influence of primary care prescribing rates for new drugs on spontaneous reporting of adverse drug reactions.
Drug Saf 2007;30:(4):357-66
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17408312&query_hl=10&itool=pubmed_docsum
HSL19381
Kreyenbuhl J, Marcus SC, West JC, Wilk J, Olfson M.
Adding or switching antipsychotic medications in treatment-refractory schizophrenia.
Psychiatr Serv 2007;58:(7):983-90
http://ps.psychiatryonline.org/cgi/content/full/58/7/983
HSL9819
Zaghi D, Maibach HI.
Survey of safety and efficacy information in drug inserts for topical prescription medications.
Am J Clin Dermatol 2007;8:(1):43-6
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17298106&query_hl=19&itool=pubmed_DocSum
HSL9996
Amoresano GV.
Branded drug reformulation: the next brand vs. generic antitrust battleground
Food Drug Law J. 2007;62:(1):249-56
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17444032&query_hl=1&itool=pubmed_DocSum
HSL9997
Kendrick LC.
FDA's regulation of prescription drug labeling: a role for implied preemption.
Food Drug Law J 2007;62:(1):227-47
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17444031&query_hl=2&itool=pubmed_DocSum
HSL9998
Hall RF, Sobotka E.
Inconsistent government policies: why FDA off-label regulation cannot survive First Amendment review under Greater New Orleans.
Food Drug Law J 2007;62:(1):1-48
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17444025&query_hl=3&itool=pubmed_DocSum
HSL10004
Lerner BH.
Ill patient, public activist: Rose Kushner's attack on breast cancer chemotherapy.
Bull Hist Med 2007 Spr;81:(1):224-40
http://muse.jhu.edu/login?uri=/journals/bulletin_of_the_history_of_medicine/v081/81.1lerner.html
HSL10008
Schwartz MB, Brownell KD.
Actions necessary to prevent childhood obesity: creating the climate for change.
J Law Med Ethics 2007 Spr;35:(1):78-89
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1748-720X.2007.00114.x
HSL10009
Schor JB, Ford M.
From tastes great to cool: children's food marketing and the rise of the symbolic.
J Law Med Ethics 2007 Spr;35:(1):10-21
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1748-720X.2007.00110.x
HSL10014
Chauhan D, Miners AH, Fischer AJ.
Exploration of the difference in results of economic submissions to the National Institute of Clinical Excellence by manufacturers and assessment groups.
Int J Technol Assess Health Care 2007 Win;23:(1):96-100
http://journals.cambridge.org/action/displayAbstract?fromPage=online&aid=651536
HSL10015
Drummond MF, Wilson DA, Kanavos P, Ubel P, Rovira J.
Assessing the economic challenges posed by orphan drugs.
Int J Technol Assess Health Care 2007 Win;23:(1):36-42
http://journals.cambridge.org/action/displayAbstract?fromPage=online&aid=651480
HSL10023
Guyatt G, Devereaux PJ, Lexchin J, Stone SB, Yalnizyan A, Himmelstein D, Woolhandler S, Zhou Q, Goldsmith G, Cook DJ, Haines T, Lacchetti C, Lavis J, Sullivan T, Mills E, Kraus S, Bhatnagar N.
A systematic review of studies comparing health outcomes in Canada and the United States
Open Medicine 2007;1:(1):E27-36
http://www.openmedicine.ca/article/view/8/1
HSL10031
Taylor CR, Capella ML, Kozup JC.
Does DTC Advertising Provide Information or Create Market Power? Evidence from the U.S. and New Zealand
Advances in International Marketing 2007;18:9-30
HSL10032
Diehl S, Mueller B, Terlutter R.
Skepticism Toward Pharmaceutical Advertising in the U.S. and Germany
Advances in International Marketing 2007;18:31-60
HSL10053
Zhang Y, Soumerai SB.
Do newer prescription drugs pay for themselves? A reassessment of the evidence
Health Affairs 2007;
http://content.healthaffairs.org/cgi/content/full/26/3/880
HSL10069
Kassirer JP.
Joint ownership: the shared responsibilities of journal editors and publishers.
Md Med 2007 Win;8:(1):10-2
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17472146&query_hl=2&itool=pubmed_DocSum
HSL10070
Hoey J.
Is editorial freedom vanishing?
Md Med 2007 Win;8:(1):8-9
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17472145&query_hl=3&itool=pubmed_DocSum
HSL10143
Canadian Pharmacists Association
Safe and Effective: The Eight Essential Elements of an Optimal Medication-Use System
: Canadian Pharmacists Association 2007
http://www.pharmacists.ca/function/shopper/ProductDetail.cfm?ProdCompanyPassed=cpa&ProdCdPassed=cpa-27024-1&PriceCategPassed=std&indexstart=1
HSL10586
Groopman J.
How Doctors Think
: Houghton & Mifflin 2007
http://www.houghtonmifflinbooks.com/catalog/titledetail.cfm?titleNumber=689664
HSL10681
Racine E, van der Loos HZ, Illes J.
Internet marketing of neuroproducts: new practices and healthcare policy challenges.
Camb Q Healthc Ethics 2007 Spr;16:(2):181-94
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17539470&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSumhttp://
HSL10880
Mastin T, Andsager JL, Choi J, Lee K.
Health Disparities and Direct-to-Consumer Prescription Drug Advertising: A Content Analysis of Targeted Magazine Genres, 1992-2002.
Health Commun 2007;22:(1):49-58
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17617013&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL10895
Copper BK.
Notes and comments 'High and dry?' The Public Readiness and Emergency Preparedness Act and liability protection for pharmaceutical manufacturers.
J Health Law 2007;40:(1):65-105
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17549932&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL10898
Jaquette I.
Merck KGaA v Integra Lifesciences I, Ltd: implications of the supreme court's decision for the people who matter most ...the consumer.
Am J Law Med 2007;33:(1):97-117
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17547356&dopt=Abstract
HSL10951
Newhouse JP, Seiguer E, Frank RG.
Was Part D a giveaway to the pharmaceutical industry?
Inquiry 2007 Spr;44:(1):15-25
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17583259&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL10964
Siekmeier R, Lutz J.
Experience with post-market surveillance of in-vitro diagnostic medical devices for lay use in Germany.
Clin Chem Lab Med 2007;45:(3):396-401
http://www.atypon-link.com/doi/abs/10.1515/CCLM.2007.058
HSL10966
Kim CH.
The case for preemption of prescription drug failure-to-warn claims.
Food Drug Law J 2007;62:(2):399-422
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17632969&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL10967
Hack EI.
Pharmaceutical global marketing practices: increased scrutiny ahead?
Food Drug Law J 2007;62:(2):343-8
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17632965&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL11037
Wilson M.
Human Rights and the Failure of Research Governance
Journal of Disability Policy Studies Summer 2007;18:(1):57-59
http://www.ingentaconnect.com/content/proedcw/jdps/2007/00000018/00000001/art00006
HSL11091
Ilku L, Vizi J.
[Off-label drug prescriptions].
Psychiatr Hung 2007;22:(1):89-94
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17642123&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL11096
Majoras DP.
Food for thought: the FTC and market influences on consumer health.
Food Drug Law J 2007;62:(2):433-9
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17632972&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL11097
Bradshaw ST.
New FDA guidance documents.
Food Drug Law J 2007;62:(2):429-31
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17632971&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL11098
Soller RW, Rice LG, Ambrose PJ.
Disclaimers in dietary supplement print advertising: the bodybuilding category as a model case for change.
Food Drug Law J 2007;62:(2):375-86
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17632967&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL11099
Reiss JB, Levy MC, Hall CR, Wartman GJ.
Your business in court--2006.
Food Drug Law J 2007;62:(2):305-42
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17632964&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL11106
McEwen J, Thompson BR, Purcell PM, Kelly LF, Krauss AS.
Widespread hyoscine hydrobromide toxicity due to contract manufacturer malpractice : the travacalm episode.
Drug Saf 2007;30:(5):375-8
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17472417&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL11127
Fisher MA.
Medicine and Industry: A Necessary but Conflicted Relationship
Perspect Biol Med. 2007 Winter;50:(1):1-6
http://muse.jhu.edu/login?uri=/journals/perspectives_in_biology_and_medicine/v050/50.1fisher.html
HSL11128
Kassirer JP.
Professional societies and industry support: what is the quid pro quo?
Perspect Biol Med 2007 Win;50:(1):7-17
http://muse.jhu.edu/login?uri=/journals/perspectives_in_biology_and_medicine/v050/50.1kassirer.html
Page 96 of 206 pages ‹ First < 94 95 96 97 98 > Last ›
